Total submissions: 21
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000118690 | SCV000169083 | benign | not specified | 2013-10-07 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Laboratory for Molecular Medicine, |
RCV000118690 | SCV000200858 | benign | not specified | 2013-02-21 | criteria provided, single submitter | clinical testing | Glu445Glu in exon 14 of TSC1: This variant is not expected to have clinical sign ificance because it does not alter an amino acid residue and is not located with in the splice consensus sequence. It has been identified in 21.9% (965/4406) of African American chromosomes from a broad population by the NHLBI Exome Sequenci ng Project (http://evs.gs.washington.edu/EVS; dbSNP rs7862221). |
Ambry Genetics | RCV000162953 | SCV000213440 | benign | Hereditary cancer-predisposing syndrome | 2014-11-19 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Eurofins Ntd Llc |
RCV000118690 | SCV000226017 | benign | not specified | 2014-07-31 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000118690 | SCV000303846 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000287833 | SCV000478237 | benign | Isolated focal cortical dysplasia type II | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Illumina Laboratory Services, |
RCV000576803 | SCV000478238 | benign | Tuberous sclerosis 1 | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Athena Diagnostics | RCV000576803 | SCV000677526 | benign | Tuberous sclerosis 1 | 2017-04-14 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000586425 | SCV000696599 | benign | not provided | 2016-05-26 | criteria provided, single submitter | clinical testing | Variant summary: The TSC1 c.1335A>G (p.Glu445Glu) variant involves the alteration of a non-conserved nucleotide, resulting in a synonymous change 2 nucleotides from the exon14-intron13 boundary. One in silico tool predicts a polymorphism outcome for this variant. 5/5 Alamut algorithms predict no significant change to the cononical splice acceptor site, while 2/5 predict a strengthening of a cryptic splice acceptor site. This variant was found in 16480/120190 control chromosomes (1225 homozygotes) at a frequency of 0.1371162, which is approximately 5485 times the estimated maximal expected allele frequency of a pathogenic TSC1 variant (0.000025), suggesting this variant is likely a benign polymorphism. In addition, multiple clinical diagnostic laboratories classified this variant as benign, and it has been reported in the literature as a normal population variant (PMID: 18538015). Taken together and based on the high allele frequency in the general population, this variant is classified as Benign. |
Division of Genomic Medicine, |
RCV000576803 | SCV001430713 | benign | Tuberous sclerosis 1 | 2020-07-10 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000586425 | SCV001472438 | benign | not provided | 2023-11-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000576803 | SCV001722509 | benign | Tuberous sclerosis 1 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000576803 | SCV002040444 | benign | Tuberous sclerosis 1 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV000576803 | SCV004015644 | benign | Tuberous sclerosis 1 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000576803 | SCV004360827 | benign | Tuberous sclerosis 1 | 2019-03-28 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000042015 | SCV004840465 | benign | Tuberous sclerosis syndrome | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000586425 | SCV005321588 | benign | not provided | criteria provided, single submitter | not provided | ||
Tuberous sclerosis database |
RCV000042015 | SCV000065797 | not provided | Tuberous sclerosis syndrome | no assertion provided | curation | ||
Genetic Services Laboratory, |
RCV000118690 | SCV000153105 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. | |
Clinical Genetics, |
RCV000118690 | SCV001920314 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000118690 | SCV001973783 | benign | not specified | no assertion criteria provided | clinical testing |